{
    "eid": "2-s2.0-85030231311",
    "title": "Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs",
    "cover-date": "2018-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        }
    ],
    "keywords": [
        "Bernese Mountain Dog",
        "gain-of-function mutation",
        "histiocytic sarcoma",
        "PTPN11 gene"
    ],
    "authors": [
        "T. Thaiwong",
        "S. Sirivisoot",
        "M. Takada",
        "V. Yuzbasiyan-Gurkan",
        "M. Kiupel"
    ],
    "citedby-count": 21,
    "ref-count": 41,
    "ref-list": [
        "Hematopoietic system",
        "Systemic histiocytosis of Bernese mountain dogs",
        "A review of histiocytic diseases of dogs and cats",
        "Malignant histiocytosis of Bernese mountain dogs",
        "Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed",
        "Inheritance of histiocytosis in Bernese mountain dogs",
        "Clinical prognostic factors in canine histiocytic sarcoma",
        "Molecular cytogenetic characterization of canine histiocytic sarcoma: a spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior",
        "The MTAP-CDKN2A locus confers susceptibility to a naturally occurring canine cancer",
        "Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment",
        "Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms",
        "Somatic mutations in histiocytic sarcoma identified by next generation sequencing",
        "Histiocytic sarcoma associated with Coombs negative acute hemolytic anemia: a rare presentation",
        "The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling",
        "Protein-tyrosine phosphatases and cancer",
        "An aggressive multifocal primary CNS histiocytosis with PTPN11 (Shp2) mutation",
        "Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines",
        "Immunohistochemical analysis of the Akt/mTOR/4E-BP1 signalling pathway in canine haemangiomas and haemangiosarcomas",
        "Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma",
        "Immunohistochemical evaluation of AKT protein activation in canine mast cell tumours",
        "Characterization, expression and function of c-Met in canine spontaneous cancers",
        "Evaluation of the protective effects of all-trans-astaxanthin on canine osteosarcoma cell lines",
        "Inhibition of the Gab2/PI3K/mTOR signaling ameliorates myeloid malignancy caused by Ptpn11 (Shp2) gain-of-function mutations",
        "Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases",
        "The tyrosine phosphatase Shp2 (PTPN11) in cancer",
        "Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew",
        "Inside the human cancer tyrosine phosphatome",
        "Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia",
        "PTPN11 mutations in childhood acute lymphoblastic leukemia occur as a secondary event associated with high hyperdiploidy",
        "Functions of Shp2 in cancer",
        "Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor",
        "Germ-line and somatic PTPN11 mutations in human disease",
        "Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells",
        "SHP2E76K mutant promotes lung tumorigenesis in transgenic mice",
        "Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations",
        "PathVisio 3: an extendable pathway analysis toolbox",
        "Presenting and exploring biological pathways with PathVisio",
        "Efficacy of dacarbazine as a rescue agent for histiocytic sarcoma in dogs",
        "Role of SHP2 in hematopoiesis and leukemogenesis",
        "Therapeutic potential of targeting the oncogenic SHP2 phosphatase",
        "Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo"
    ],
    "affiliation": [
        {
            "affiliation-city": "East Lansing",
            "@id": "60031707",
            "affilname": "Michigan State University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031707",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Fulbright foundation",
        "Michigan State University"
    ]
}